Drug interactions
Diphenoxylate-atropine + Selegiline transdermal
Severity: Major
Diphenoxylate-atropine and Selegiline transdermal: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Diphenoxylate is structurally related to meperidine, and MAO inhibitors given with opioids of this type carry a risk of hypertensive crisis, hyperpyrexia, and CNS excitation or depression. Labeling for diphenoxylate-atropine warns against use with MAO inhibitors.
What this interaction means in plain words
Diphenoxylate-atropine and Selegiline transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Probable MAO inhibition-related potentiation of opioid and serotonergic or adrenergic effects; the exact mechanism is not fully established.
What to do
Avoid the combination during and for a washout period after selegiline use. Use a non-opioid antidiarrheal alternative.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Diphenoxylate-atropine and Selegiline transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Diphenoxylate-atropine
- Diphenoxylate-atropine + Isocarboxazid Contraindicated
- Diphenoxylate-atropine + Phenelzine Contraindicated
- Diphenoxylate-atropine + Tranylcypromine Contraindicated
- Alfentanil + Diphenoxylate-atropine Major
- Alvimopan + Diphenoxylate-atropine Major
- Amitriptyline + Diphenoxylate-atropine Major
Frequently asked questions
Can I take Diphenoxylate-atropine with Selegiline transdermal?
MediHelp rates the interaction as major. Diphenoxylate-atropine and Selegiline transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Diphenoxylate is structurally related to meperidine, and MAO inhibitors given with opioids of this type carry a risk of hypertensive crisis, hyperpyrexia, and CNS excitation or depression. Labeling for diphenoxylate-atropine warns against use with MAO inhibitors.
How serious is the interaction between Diphenoxylate-atropine and Selegiline transdermal?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination during and for a washout period after selegiline use. Use a non-opioid antidiarrheal alternative.
What other medicines interact with Diphenoxylate-atropine?
MediHelp also lists interactions of Diphenoxylate-atropine with, for example, Isocarboxazid, Phenelzine, Tranylcypromine. The full list is on the Diphenoxylate-atropine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
